Japan colorectal tumor prevention study: randomized controlled trial of curcumin - Japan colorectal tumor prevention study: randomized controlled trial of curcumin (J-CAP-C)

Management Committee0 个研究点目标入组 600 人开始时间: 2015年9月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•# Patients with a medical history of submucosal or deeper colorectal cancer. # Patients currently taking antithrombotics such as Bayaspirin, Bufferin, Panaldine, Warfarin, Persantin and NOAC. # Patients who have undergone colorectal resection (those who have undergone appendectomy are allowed to participate in the study). # Patients with familial colorectal adenoma. # Patients with any existing cancer at the time of participation in the study. # Patients with known allergy to curcumin. # Patients currently taking anticancer drugs. # Women who are or may be pregnant during the study period. # Patients currently taking NSAIDs at least 3 times weekly, for example, as a analgesic. # Patients with ulcerative colitis or Crohn's disease # Patients with bleeding tendency or platelet count less than 70,000. # Patient taking turmeric as a supplement. # Patient deemed inappropriate by a doctor

发起方

Management Committee